您当前的位置:
首页 >
文章列表页 >
Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy
LETTER TO THE EDITOR | 更新时间:2025-12-13
上一篇|下一篇
    • Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy

    • Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy

    • “在xxx领域,xx专家取得了重大的研究进展。通过建立xx体系/探索xx主题/验证xx猜想,他们为解决xx问题提供了解决方案/为xx研究开辟了新方向/为xx体系的构建奠定了基础。”
    • Xin-Yu Zhu ,Wei-Yi Zhou ,Tuo Li
    • MMR 2025年12卷第8期 页码:1326-1328
    • DOI: 10.1186/s40779-025-00590-7     

      中图分类号:
    • 录用:2025-01-02 ,

    移动端阅览

  •  
  •  
  • AI导读

  • HTML全文

  • 图( 1 ) 表( 0 )

  • 参考文献

  • 出版信息

  • 数据统计

42

浏览量

54

下载量

0

CSCD

文章被引用时,请邮件提醒。
提交
工具集
  • BibTeX下载
  • Endnote下载
  • RefMan 下载
  • NoteExpress下载
  • NoteFirst下载

相关文章

Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity
Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain
Immune microenvironment dynamics in pregnant patients with concomitant autoimmune diseases: mechanisms, challenges, and clinical significance
From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients

相关作者

Tuo Li

相关机构

暂无数据